Schrodinger, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
SDGR on Nasdaq
Industry
Pharmaceutical Preparations
Location
1540 Broadway, 24 Th Floor, New York, NY

Insiders trading volume in the past year

Schrodinger, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David E. Shaw 10%+ Owner $549M Jun 14, 2021
Richard Friesner Director $5.38M Jun 18, 2024
Jenny Herman SVP & Controller $540K -$22.3K -3.96% Mar 4, 2024
Yvonne Tran Evp, Clo & Cpo $338K -$21.4K -5.96% Mar 4, 2024
Robert Lorne Abel EVP, Chief Scientific Officer, Platform $257K -$33.2K -11.4% Mar 21, 2024
Kenneth Patrick Lorton EVP, CTO & COO, Software $183K -$25.5K -12.3% Mar 21, 2024
Geoffrey Craig Porges Evp & Cfo $150K -$87.4K -36.8% Mar 4, 2024
Gary Ginsberg Director $48.8K Jun 18, 2024
Arun Oberoi Director $48.8K Jun 18, 2024
Gary Sender Director $48.8K Jun 18, 2024
Michael Lynton Director $48.8K Jun 18, 2024
Rosana Kapeller-Libermann Director $48.8K Jun 18, 2024
Jeffrey Chodakewitz Director $48.8K Jun 18, 2024
Nancy Thornberry Director $48.8K Jun 18, 2024
Margaret Dugan Chief Medical Officer $18K Mar 4, 2024
Ramy Farid President & CEO, Director Mar 4, 2024
Karen Akinsanya President of R&D, Therapeutics Mar 4, 2024
Joel Lebowitz Evp & Cfo Sep 1, 2021

Recent Insider Transactions by Companies or Individuals for Schrodinger, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.